Tue, November 16, 2021

Michael Ulz Initiated (XLO) at Buy and Held Target at $32 on, Nov 16th, 2021

Michael Ulz of Morgan Stanley, Initiated "Xilio Therapeutics, Inc." (XLO) at Buy and Held Target at $32 on, Nov 16th, 2021.

Michael, nor any peers, have made any analyst calls on XLO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30